BriaCell Therapeutics Corp. (BCTX)
3.94
-0.19
(-4.60%)
USD |
NASDAQ |
Feb 20, 14:29
BriaCell Therapeutics EPS Diluted (Quarterly) : -4.351 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hear AtLast Holdings, Inc. | -0.0003 |
| Pharmagreen Biotech, Inc. | 0.0001 |
| CeCors, Inc. | -- |
| Venus Concept, Inc. | -12.14 |
| Achieve Life Sciences, Inc. | -0.2831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.278M |
| Total Expenses (Quarterly) | 8.198M |
| Enterprise Value | 14.85M |
| Earnings Yield | -1.23K% |
| Normalized Earnings Yield | -1293.13 |